The pharmaceutical world is observing a significant shift in blood sugar treatment with the emergence of GLP-1 skin applications. These devices offer a potentially more convenient alternative to shots of GLP-1 receptor agonists, reducing the requirement of daily needle sticks. The innovation releases the medication directly through the skin, arguab